Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWag Payment Regulatory News (WPS)

Share Price Information for Wag Payment (WPS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 68.00
Bid: 67.00
Ask: 67.80
Change: 2.20 (3.34%)
Spread: 0.80 (1.194%)
Open: 68.80
High: 68.80
Low: 67.00
Prev. Close: 65.80
WPS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Stabilisation Notice

8 Oct 2021 07:00

RNS Number : 4320O
Morgan Stanley & Co. Int'l plc
08 October 2021
 

8 October 2021

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

W.A.G payment solutions plc

Pre-Stabilisation Notice

Morgan Stanley & Co. International plc (contact: James Manson-Bahr; telephone: +44 20 7425-3672) hereby gives notice, as Coordinating Stabilisation Manager, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities in accordance with Regulation (EU) No 596/2014 (Market Abuse Regulation) and Commission Delegated Regulation (EU) 2016/1052 and/or the UK FCA Stabilisation Binding Technical Standards. Stabilisation transactions aim at supporting the market price of the securities during the stabilisation period. Stabilisation may not necessarily occur and it may cease at any time.

Securities

Issuer:

W.A.G payment solutions plc (the "Company" or "Eurowag")

ISIN:

GB00BLGXWY71

Description:

Initial Public Offering

Offer size:

124,000,000 ordinary shares (excluding the overallotment option)

Offer price:

150 pence per ordinary share

Stabilisation

Stabilisation Manager(s):

Morgan Stanley & Co. International plc

Stabilisation period expected to start on:

8 October 2021

Stabilisation period expected to end no later than:

5 November 2021

Stabilisation trading venue:

London Stock Exchange, Over-the-Counter (OTC) and other trading venues

Over-allotment & Greenshoe Option:

Terms:

In connection with the Offer, Morgan Stanley, as Stabilising Manager, may (but will be under no obligation to), to the extent permitted by applicable law, over-allot Ordinary Shares up to a maximum of 10% of the total number of the Offer Shares (prior to any exercise of the Over-allotment Option) or effect other transactions with a view to supporting the market price of the Ordinary Shares at a level higher than that which might otherwise prevail in the open market for a period of no more than 30 calendar days after the date of commencement of conditional dealings of the shares on the London Stock Exchange. Such transactions may be effected on the London Stock Exchange, in the over-the-counter markets or otherwise. There is no obligation on the Stabilising Manager to undertake stabilisation transactions. Such transactions, if commenced, may be discontinued at any time without prior notice and must be brought to an end no later than 30 calendar days after the date of commencement of conditional dealings of the Ordinary Shares on the London Stock Exchange (the "Stabilisation Period"). In no event will measures be taken to stabilise the market price of the Ordinary Shares above the Offer Price. Save as required by law, the Stabilising Manager does not intend to disclose the extent of any stabilisation transactions under the Offer.

For the purposes of allowing the Stabilising Manager to cover short positions resulting from any such over-allocations and/or from sales of Ordinary Shares effected by it during the Stabilisation Period, it is expected that certain shareholders of the Company will grant to the Stabilising Manager the Overallotment Option, pursuant to which the Stabilising Manager may purchase or procure purchasers for up to a maximum of 10% of the total number of Ordinary Shares comprised in the Offer (the "Over-allotment Shares") at the Offer Price. The Over-allotment Option shall be exercisable in whole or in part, upon notice by the Stabilising Manager, at any time on or before the 30th calendar day after the commencement of conditional dealings in the Ordinary Shares on the London Stock Exchange.

Any Over-allotment Shares made available pursuant to the Over-allotment Option will rank pari passu in all respects with the Ordinary Shares, including for all dividends and other distributions declared, made or paid on the Ordinary Shares, will be purchased on the same terms and conditions as the Ordinary Shares in the Offer and will form a single class for all purposes with the other Ordinary Shares.

Number of shares covered by Over-allotment Option:

12,400,000 Ordinary Shares

Duration:

This option may be executed in full or in part at any time during the Stabilisation Period.

 

Important Notice:

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, the UK before the publication of a prospectus in relation to the securities which has been approved by the competent authority in the UK in accordance with Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (the "UK Prospectus Regulation"), this announcement and the offer are only addressed to and directed at persons in the UK who are qualified investors within the meaning of the UK Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in the UK.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with Regulation (EU) 2017/1129 (the "EEA Prospectus Regulation") (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the EEA Prospectus Regulation), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the EEA Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAMRBBTMTIMTPB
12
Date   Source Headline
26th Mar 20247:00 amRNSPreliminary results for the year ended 31 Dec 2023
20th Feb 20243:48 pmRNSTermination of SPA for additional stake in JITpay
7th Feb 20242:35 pmRNSBoard Changes
18th Jan 20247:00 amRNSTrading Update
26th Oct 20232:48 pmRNSStatement re Shareholder Engagement
24th Oct 20237:00 amRNSTrading Update
11th Oct 20237:00 amRNSCapital Markets Day
7th Sep 20237:00 amRNSHalf-year Report
1st Sep 20231:52 pmRNSTotal Voting Rights
4th Jul 202310:59 amRNSDirector Declaration
4th Jul 20237:02 amRNSCall option to acquire JITpay
12th May 20239:11 amRNSDirector/PDMR Shareholding
11th May 20235:51 pmRNSResult of AGM
3rd May 202311:01 amRNSDirector Declaration
25th Apr 20233:45 pmRNSDirector/PDMR Shareholding
25th Apr 20237:00 amRNSDirectorate Changes and AGM Update
25th Apr 20237:00 amRNSTrading Update
12th Apr 20235:53 pmRNSNotice of AGM 2023
21st Mar 20237:30 amRNSAnnual Report 2022
17th Mar 20234:35 pmRNSPrice Monitoring Extension
16th Mar 20237:00 amRNSPreliminary results for the year ended 31 Dec 2022
15th Mar 20236:31 pmRNSCompletion of acquisition of Inelo
9th Mar 20232:27 pmRNSResult of General Meeting
3rd Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20237:09 amRNSAppointment of Chief Financial Officer
27th Feb 20234:35 pmRNSPrice Monitoring Extension
27th Feb 20237:00 amRNSAppointment of Joint Corporate Broker
20th Feb 20232:36 pmRNSPublication of Circular, Notice of General Meeting
19th Jan 20237:00 amRNSTrading Update
9th Jan 20234:35 pmRNSPrice Monitoring Extension
20th Dec 20227:00 amRNSAcquisition of 30% of Sygic and update on Inelo
15th Dec 20224:40 pmRNSSecond Price Monitoring Extn
15th Dec 20224:35 pmRNSPrice Monitoring Extension
29th Nov 20224:40 pmRNSSecond Price Monitoring Extn
29th Nov 20224:36 pmRNSPrice Monitoring Extension
1st Nov 20222:07 pmRNSDirector/PDMR Shareholding
25th Oct 20224:40 pmRNSSecond Price Monitoring Extn
25th Oct 20224:35 pmRNSPrice Monitoring Extension
25th Oct 20227:01 amRNSTrading Update and Board Changes
25th Oct 20227:00 amRNSEurowag to acquire Inelo
6th Oct 20224:35 pmRNSPrice Monitoring Extension
22nd Sep 20227:00 amRNSEurowag to refinance existing debt
13th Sep 20228:00 amRNSAdmission to FTSE 250 Index
8th Sep 20225:30 pmRNSMeggitt - Update
6th Sep 20227:00 amRNSHalf-year Report
1st Jul 20227:00 amRNSEurowag completes the acquisition of WebEye assets
23rd Jun 20227:00 amRNSUpdate on completion of WebEye assets acquisition
26th May 20223:54 pmRNSResult of AGM
24th May 20224:40 pmRNSSecond Price Monitoring Extn
24th May 20224:35 pmRNSPrice Monitoring Extension
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.